English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduHigh-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.
Tag: Heparin
High Blood Viscosity Can Predict Higher Risk of Death in Hospitalized COVID-19 Patients
EMBARGOED UNTIL JULY 18, 2022, 2PM EST Study Title: “Association of Blood Viscosity with Mortality among Patients Hospitalized with COVID-19” Journal: Journal of the American College of Cardiology – *Embargoed until July…
Canadian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients
The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.
Heparin-based Blood Purification Protects Baboon Kidneys in Severe Pneumonia, Sepsis
Article title: Heparin-based blood purification attenuates organ injury in baboons with S. pneumoniae pneumonia Authors: Lingye Chen, Bryan D. Kraft, Victor L. Roggli, Zachary R. Healy, Christopher W. Woods, Ephraim L. Tsalik, Geoffrey S. Ginsburg, David M. Murdoch, Hagir B.…
URI, Rensselaer collaborate on fast, accurate test with potential of verifying purity of pharmaceutical heparin
Researchers from the University of Rhode Island and Rensselaer Polytechnic Institute have teamed up to perfect a fast, accurate test combining the use of a solid-state nanopore and machine learning to verify the identity and purity of synthetic heparan sulfate
Common Bacteria Modified To Make Designer Sugar-Based Drug
Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.
Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for COVID-19 and Insight on Best Potential Regimens
Study is the basis of a new international clinical trial